Merck & Co

Merck & Co EBITDA per Employee

The EBITDA per Employee of Merck & Co (MRK) as of Oct 26, 2026 is 313,146.67 USD. In the previous year, EBITDA per Employee was 269,613.33 USD — a change of 16.15% (higher).

EBITDA per Employee

313,146.67USD

YoY

16.15%

Last updated:

EBITDA per Employee of Merck & Co is 2025 313,146.67 USD. EBITDA per Employee of Merck & Co was 2024 269,613.33 USD. It decreases by 16.15% higher compared to the previous year.

The Merck & Co EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
119,080.00 USD
Jan 1, 2019
105,680.00 USD
Jan 1, 2020
84,266.67 USD
Jan 1, 2021
186,253.33 USD
Jan 1, 2022
243,760.00 USD
Jan 1, 2023
39,386.67 USD
Jan 1, 2024
269,613.33 USD
Jan 1, 2025
313,146.67 USD
The Merck & Co EBITDA per Employee history
YEAREBITDA per EmployeeYoY
313,146.67USD+16.15%
269,613.33USD+584.53%
39,386.67USD-83.84%
243,760.00USD+30.88%
186,253.33USD+121.03%
84,266.67USD-20.26%
105,680.00USD-11.25%
119,080.00USD+31.40%
90,626.67USD+23.60%
73,320.00USD-27.14%
100,626.67USD+12.93%
89,106.67USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck & Co Stock analysis

What does Merck & Co do? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck & Co stock

EBITDA per Employee of Merck & Co is 313,146.67 USD in 2025.

EBITDA per Employee of Merck & Co changed from 269,613.33 USD to 313,146.67 USD, representing a 16.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Merck & Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Merck & Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Merck & Co

All Key Metrics — Merck & Co